The short-term prostate-specific antigen velocity before biopsy can be used to predict prostatic histology

BJU International

Volumn 85, Issue 7, 2000, Pages 847-850

  Lynn, N N K ^a   Collins, G N ^a   Reilly, P M ^a  

^a STEPPING HILL HOSPITAL   (United Kingdom)

Author keywords

Histology; Prostate biopsy; Prostate cancer; PSA velocity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0034010155     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00620.x     Document Type: Article

References (23)

1. 1 Oesterling JE. Cooncr WH, Jacobsen SJ, Guess HA, Lieber MM. Influence of patient age on the serum PSA concentration. Urol Clin North Am 1993; 20: 671-80
2. 2 Collins GN, Lee RJ. McKelvie GB, Rogers AC, Hehir M. Relationship between PSA, prostate volume and age in the benign prostate. Br J Urol 1993; 71: 445-50
3. 3 Haese A, Graefen M, Noklus J, Hammerer P, Huland E, Huland H. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia. J Urol 1997; 158: 2188-92
4. 4 Carter HB, Pearson JD. PSA velocity for the diagnosis of early prostate cancer. Urol Clin North Am 1993; 20: 665-70
5. 5 Collins GN, Raab GM, Hehir M, King B, Garraway WM. Reproducibility and observer variability of transrectal ultrasound measurements of prostate volume. Ultrasound Med Biol 1995; 21: 1101-5
6. 6 Rhodes T, Girman CJ, Jacobsen SJ, Roberts RO, Guess HA, Lieber MM. Longitudinal prostate growth rates during 5 years in randomly selected community men 40-79 years old. J Urol 1999; 161: 1174-9
7. 7 Carter HB, Pearson JD, Metter J et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992; 267: 2215-20
8. 8 Blijenberg BG, Eman I, Boeve ER, Mossner E, Uhl W. The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen. Eur J Clin Chem Clin Biochem 1995; 33: 383-92
9. 9 Collins GN, Martin PJ, Wynn-Davies A, Brooman PJ, O'Reilly PH. The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostatic specific antigen, and the free-to-total prostatic specific antigen ratio in clinical practice. J Urol 1997; 157: 1744-7
10. 10 Collins MM, Kleinman K, Barry MJ, Meigs JB, Yurgalevitch SM, McKinlay JB. Prostate specific antigen levels: Effect of sexual activity. Prostate J 1999; 1: 82-7
11. 11 Heidenreich A, Vorreuther R, Neubauer S, Westphal J, Engelmann UH. Moul JW. The influence of ejaculation on serum levels of prostate specific antigen. J Urol 1997: 157: 209-11
12. 12 Tchetgen M, Song JT, Strawderman M, Jacobsen SJ, Osterling JE. Ejaculation increases the serum prostate-specific antigen concentration. Urology 1996; 47: 551-6
13. 13 El-Shirbiny AM, Nilson T, Pawar HN. Serum prostate-specific antigen: Hourly change/24 hours compared with prostatic acid phosphatase. Urology 1990; 35: 88-92
14. 14 Akimoto S, Masai M, Shimazaki J. Relationship between diurnal rhythm of serum testosterone and two prostatic markers (PSA and PAP) in untreated prostate cancer. Urology 1994; 43: 357-41
15. 15 Roehrborn CG, Pickens GJ, Carmody T. Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population. Urology 1996; 47: 59-66
16. 16 Morote J. Encabo G, Lopez M, De Torres IM. Individual variations of total and percent free serum prostatic specific antigen: could they change the indication of prostatic biopsy? Oncol Rep 1999; 6: 887-90
17. 17 Morote J, Raventos CX, Lorente JA, Enbabo G, Lopez M, de Torres I. Intra-individual variation of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination. Eur Urol 1999; 36: 111-5
18. 18 Riehmann M, Rhodes PR, Cook YD, Grose GS, Bruskewitz RC. Analysis of variation in prostate-specific antigen values. Urology 1993; 42: 390-7
19. 19 Gerber GS, Gornik HL, Goldfischer ER, Chodek GW, Rukstalis DB. Evaluation of changes in prostate specific antigen in clinically localized prostate cancer managed without initial therapy. J Urol 1998; 159: 1243-6
20. 20 Zewig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77
21. 21 Komatsu K, Wehner N, Prestigiacomo AF, Chen Z, Stamey TA. Physiologic (intra-individual) variation of serum prostate-specific antigen in 814 men from a screening population. Urology 1996; 47: 343-6
22. 22 Ornstein DK, Smith DS, Rao GS, Basler JW, Ratliff TL, Catalona WJ. Biologic variation of total, free and percent free serum prostate specific antigen levels in screening volunteers. J Urol 1997; 157: 2179-82
23. 23 Collins GN, Alexandrou K, Wynn-Davies A, Mobley S, O'Reilly PH. Free prostatic specific antigen 'in the field': a useful adjunct to standard clinical practice. BJU Int 1999; 83: 1000-2